Guideline 12.5 — Approach to the Dysmorphic Infant

BEDSIDE ACTION BOX

First stabilize and treat any life-threatening problem (airway/breathing/circulation, hypoglycemia, sepsis, duct-dependent cardiac disease) — dysmorphology assessment comes after safety.
Take a structured history (pregnancy, exposures, fetal movements, family tree/consanguinity) and perform a systematic head-to-toe examination; measure growth parameters (weight/length/head).
Distinguish major anomalies (medically/surgically significant — e.g., cardiac, cleft palate, limb defect) from minor anomalies (of cosmetic significance, but ≥3 minor anomalies raise the chance of an underlying syndrome/major anomaly).
Classify the mechanism — malformation, deformation, disruption, or dysplasia — and consider whether findings form a recognizable syndrome/sequence/association.
Screen for internal anomalies (echocardiogram, renal/cranial ultrasound as indicated), obtain consented clinical photographs, and involve Clinical Genetics for testing (see 12.2) and counseling.

1. Overview

Overview

Assessing the dysmorphic infant is a structured clinical skill, not pattern-guessing. The goal is to describe findings accurately and objectively, classify them by mechanism and significance, screen for associated internal anomalies, and — with Clinical Genetics — pursue a unifying diagnosis where possible, which informs prognosis, management, and family counseling. Throughout, care is compassionate and avoids premature or stigmatizing labels.

Why This Topic Matters

A dysmorphic feature may be an isolated minor variant or the visible clue to a syndrome with important internal anomalies (e.g., cardiac, renal). A structured approach avoids both missing serious associated conditions and mislabeling a normal variant as pathology.

2. Who This Guideline Applies To

Scope

Neonates with dysmorphic features, single or multiple congenital anomalies, or growth abnormalities of uncertain cause.
Teams coordinating examination, screening, photography, and genetics referral.
Cross-references: genetic testing (12.2), chromosomal syndromes (12.3), inborn errors (12.1), hypotonia (9.6), and congenital heart disease (3.3).

3. Key Definitions

Term	Definition
Malformation	Intrinsically abnormal developmental process (e.g., cardiac defect, neural tube defect).
Deformation	Abnormal form/position from mechanical forces on normal tissue (e.g., positional talipes from oligohydramnios).
Disruption	Breakdown of normally forming tissue (e.g., amniotic bands).
Dysplasia	Abnormal cellular organization within a tissue (e.g., skeletal dysplasia).
Syndrome / sequence / association	A recognized pattern (single cause) / cascade from one anomaly / non-random co-occurrence (e.g., VACTERL).

4. Mechanism Framework

Classify Before Diagnosing

Decide whether each finding is a malformation, deformation, disruption, or dysplasia — this shapes cause, recurrence risk, and counseling.
Consider whether the findings represent a syndrome (one cause, multiple features), a sequence (one primary anomaly with downstream effects, e.g., Pierre Robin), or an association (e.g., VACTERL, CHARGE).
Distinguish isolated single anomalies from multiple-anomaly patterns (higher chance of a genetic diagnosis).

5. History

Targeted Questions

Pregnancy: antenatal scans/screening, liquor volume (oligo/polyhydramnios), fetal movements, growth, exposures (drugs, alcohol, teratogens, maternal diabetes/illness).
Birth: gestation, presentation, complications.
Family: three-generation pedigree, consanguinity, recurrent miscarriage, affected relatives, ethnic background.

6. Systematic Examination

Head-to-Toe, Objective, Measured

Growth parameters (weight, length, head circumference) plotted; overall proportions/symmetry.
Craniofacies (skull shape, fontanelles, eyes/spacing, ears position/form, nose, mouth/palate, jaw); neck.
Chest/heart/lungs; abdomen (organomegaly, wall defects, umbilicus); genitalia (ambiguity — see 4.1) and anus.
Limbs and digits (number, form, creases), spine (midline defects/sacral dimple), skin (pigmentary/lesions), and neurology/tone (see 9.6).
Describe findings objectively (use standard terms/measurements) rather than jumping to a label.

7. Major vs Minor Anomalies

Type	Definition	Examples
Major	Medical/surgical or functional significance.	Congenital heart disease, cleft palate, neural tube defect, limb reduction, renal malformation.
Minor	Mainly cosmetic; common as isolated variants.	Single palmar crease, epicanthic folds, preauricular tag/pit, clinodactyly, sacral dimple.

The "Three or More" Rule

A single minor anomaly is often a normal variant, but three or more minor anomalies substantially increase the likelihood of an underlying major anomaly or syndrome — prompt a careful internal-anomaly screen and genetics involvement.

8. Assessment Algorithm

Stabilize first

Treat life-threatening issues (ABCs, glucose, sepsis, duct-dependent CHD) before dysmorphology work-up.

History + systematic exam

Pregnancy/family history; head-to-toe examination; growth parameters; describe findings objectively.

Classify

Malformation/deformation/disruption/dysplasia; single vs multiple; major vs minor; syndrome/sequence/association?

Screen internal anomalies

Echocardiogram; renal/cranial/abdominal ultrasound; skeletal survey and other tests as the pattern indicates.

Photograph, test, involve genetics

Consented clinical photographs; genetic testing (microarray/panels/exome as appropriate — see 12.2); Clinical Genetics referral and counseling.

⚠ Do-not-miss

Life-threatening problems first; occult major internal anomalies (cardiac/renal); time-critical diagnoses (metabolic/CAH); and the "≥3 minor anomalies" clue.

9. Investigation & Testing

Phenotype-Directed (see 12.2)

Internal-anomaly screening: echocardiography, and cranial/renal/abdominal ultrasound; skeletal survey and ophthalmology/hearing as indicated.
Genetic testing guided by the phenotype: chromosomal microarray for multiple anomalies, targeted testing/panels for recognizable patterns, and (rapid) trio exome/genome where indicated — with consent and genetics input (see 12.2).
Metabolic screen if the picture suggests an inborn error (see 12.1); obtain samples before transfusion/in crisis when relevant.
Take consented clinical photographs to aid remote dysmorphology review.

10. Red Flags

Prioritize

Any life-threatening problem (duct-dependent cardiac disease, airway compromise, hypoglycemia, sepsis, metabolic crisis) — treat first.
Multiple anomalies or ≥3 minor anomalies — higher chance of a syndrome with internal anomalies.
Ambiguous genitalia (urgent — see 4.1) and features suggesting a treatable metabolic/endocrine condition.
Family history/consanguinity suggesting a recessive or inherited condition.

11. Precautions

Safety Cautions

Stabilize life-threatening problems before dysmorphology assessment.
Describe findings objectively; avoid premature or stigmatizing labels before confirmation.
Always screen for internal anomalies (echocardiogram at minimum) with multiple/major findings.
Obtain consent for photographs and genetic testing; involve Clinical Genetics.
Counsel sensitively and non-directively; provide accurate information and support.

12. Escalation & Family Support

Family-Centered Communication

"We've noticed some features in your baby that we'd like to understand better. We'll examine your baby carefully, check the heart and other organs, and involve a genetics specialist to look for a cause."
"This helps us plan the best care and give you accurate information. We'll take it step by step and support you throughout."

13. Key Pearls

High-Value Clinical Pearls

Stabilize life-threatening problems before the dysmorphology work-up.
Describe objectively; classify by mechanism (malformation/deformation/disruption/dysplasia) and significance (major vs minor).
Three or more minor anomalies raise the chance of an underlying major anomaly/syndrome.
Screen internal anomalies (echocardiogram, renal/cranial ultrasound) with multiple/major findings.
Phenotype-directed genetic testing (microarray → panels/exome) with consent and Clinical Genetics (see 12.2).
Take consented photographs; counsel sensitively and non-directively.

14. Common Mistakes to Avoid

Mistake	Why it harms	Better practice
Dysmorphology before stabilization.	Missed emergencies.	Treat life-threatening problems first.
Premature labeling.	Error; distress.	Describe objectively; confirm.
Skipping internal-anomaly screen.	Missed cardiac/renal disease.	Echo + ultrasound as indicated.
Ignoring ≥3 minor anomalies.	Missed syndrome.	Screen and refer to genetics.
Testing without consent/genetics.	Ethical/quality issues.	Consent; phenotype-directed testing (12.2).

15. Board-Style High-Yield Summary

Key Takeaways

Stabilize life-threatening problems first; then take a structured history and systematic head-to-toe examination with growth parameters.
Classify findings by mechanism (malformation/deformation/disruption/dysplasia) and significance (major vs minor), and consider syndrome/sequence/association.
Three or more minor anomalies raise the likelihood of an underlying major anomaly or syndrome.
Screen for internal anomalies (echocardiogram, renal/cranial ultrasound) with multiple/major findings.
Use phenotype-directed genetic testing (microarray → panels/exome) with consent and Clinical Genetics involvement (see 12.2).
Describe objectively, take consented photographs, and counsel sensitively and non-directively.

16. References

1.Jones KL, et al. Smith's Recognizable Patterns of Human Malformation (dysmorphology approach).
2.West Midlands Neonatal ODN. Assessment of the Dysmorphic Infant; Genetics. Neonatal Guidelines 2025–28.
3.Hennekam RCM, et al. Elements of Morphology — standardized terminology (Am J Med Genet).
4.Baylor College of Medicine. Guidelines for Acute Care of the Neonate, Ed. 33, 2025–2026 (genetics/dysmorphology).
5.Ministry of Health Belize. Neonatal Clinical Practice Guidelines 2018–2021.

Back to Clinical Guideline Hubs

Chapter 12.5 — Approach to the Dysmorphic Infant